Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study

Background: The long-term outcome for patients with aggressive non-Hodgkin's lymphoma (NHL) is poor. Consequently, the European Organization for Research and Treatment of Cancer Lymphoma Group designed a prospective randomized trial to investigate whether high-dose chemotherapy plus autologous...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 2001-01, Vol.93 (1), p.22-30
Hauptverfasser:	Kluin-Nelemans, Hanneke C., Zagonel, Vittorina, Anastasopoulou, Anastasia, Bron, Dominique, Roozendaal, Klaas J., Noordijk, Ed M., Musson, Helen, Teodorovic, Ivana, Maes, Brigitte, Carbone, Antonino, Carde, Patrice, Thomas, José
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bleomycin - administration & dosage Bone marrow Cause of Death Chemotherapy Clinical trials Cyclophosphamide - administration & dosage Doxorubicin - administration & dosage Drug Administration Schedule Europe Female Hematopoietic Stem Cell Transplantation Humans Lymphoma Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - radiotherapy Lymphoma, Non-Hodgkin - therapy Male Medical sciences Middle Aged Pharmacology. Drug treatments Prednisone - administration & dosage Prospective Studies Radiotherapy, Adjuvant Survival Analysis Teniposide - administration & dosage Transplantation, Autologous Transplants & implants Treatment Outcome Vincristine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!